CTI BioPharma Statistics
Total Valuation
SNCY has a market cap or net worth of $548.50 million. The enterprise value is $1.07 billion.
Important Dates
The last earnings date was Thursday, July 31, 2025, after market close.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SNCY has 53.20 million shares outstanding. The number of shares has decreased by -2.09% in one year.
| Current Share Class | 53.20M |
| Shares Outstanding | 53.20M |
| Shares Change (YoY) | -2.09% |
| Shares Change (QoQ) | -1.32% |
| Owned by Insiders (%) | 2.16% |
| Owned by Institutions (%) | 111.46% |
| Float | 46.25M |
Valuation Ratios
The trailing PE ratio is 9.63 and the forward PE ratio is 6.21. SNCY's PEG ratio is 0.17.
| PE Ratio | 9.63 |
| Forward PE | 6.21 |
| PS Ratio | 0.50 |
| Forward PS | 0.47 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | 4.16 |
| P/OCF Ratio | 3.38 |
| PEG Ratio | 0.17 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.07, with an EV/FCF ratio of 8.14.
| EV / Earnings | 18.23 |
| EV / Sales | 0.98 |
| EV / EBITDA | 5.07 |
| EV / EBIT | 9.52 |
| EV / FCF | 8.14 |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.92.
| Current Ratio | 0.63 |
| Quick Ratio | 0.10 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | 2.67 |
| Debt / FCF | 4.26 |
| Interest Coverage | 2.75 |
Financial Efficiency
Return on equity (ROE) is 10.15% and return on invested capital (ROIC) is 5.87%.
| Return on Equity (ROE) | 10.15% |
| Return on Assets (ROA) | 4.47% |
| Return on Invested Capital (ROIC) | 5.87% |
| Return on Capital Employed (ROCE) | 9.42% |
| Revenue Per Employee | $350,253 |
| Profits Per Employee | $18,749 |
| Employee Count | 3,141 |
| Asset Turnover | 0.70 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SNCY has paid $17.74 million in taxes.
| Income Tax | 17.74M |
| Effective Tax Rate | 23.15% |
Stock Price Statistics
The stock price has decreased by -21.30% in the last 52 weeks. The beta is 1.62, so SNCY's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | -21.30% |
| 50-Day Moving Average | 11.86 |
| 200-Day Moving Average | 13.35 |
| Relative Strength Index (RSI) | 29.84 |
| Average Volume (20 Days) | 1,038,622 |
Short Selling Information
The latest short interest is 4.17 million, so 7.83% of the outstanding shares have been sold short.
| Short Interest | 4.17M |
| Short Previous Month | 4.73M |
| Short % of Shares Out | 7.83% |
| Short % of Float | 9.01% |
| Short Ratio (days to cover) | 3.79 |
Income Statement
In the last 12 months, SNCY had revenue of $1.10 billion and earned $58.89 million in profits. Earnings per share was $1.07.
| Revenue | 1.10B |
| Gross Profit | 353.76M |
| Operating Income | 112.80M |
| Pretax Income | 67.37M |
| Net Income | 58.89M |
| EBITDA | 211.84M |
| EBIT | 112.80M |
| Earnings Per Share (EPS) | $1.07 |
Full Income StatementBalance Sheet
The company has $37.00 million in cash and $562.30 million in debt, giving a net cash position of -$525.30 million or -$9.87 per share.
| Cash & Cash Equivalents | 37.00M |
| Total Debt | 562.30M |
| Net Cash | -525.30M |
| Net Cash Per Share | -$9.87 |
| Equity (Book Value) | 613.00M |
| Book Value Per Share | 11.52 |
| Working Capital | -132.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $162.26 million and capital expenditures -$30.33 million, giving a free cash flow of $131.93 million.
| Operating Cash Flow | 162.26M |
| Capital Expenditures | -30.33M |
| Free Cash Flow | 131.93M |
| FCF Per Share | $2.48 |
Full Cash Flow StatementMargins
Gross margin is 32.16%, with operating and profit margins of 10.25% and 5.35%.
| Gross Margin | 32.16% |
| Operating Margin | 10.25% |
| Pretax Margin | 6.97% |
| Profit Margin | 5.35% |
| EBITDA Margin | 19.26% |
| EBIT Margin | 10.25% |
| FCF Margin | 11.99% |
Dividends & Yields
SNCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.09% |
| Shareholder Yield | 2.09% |
| Earnings Yield | 10.74% |
| FCF Yield | 24.05% |
Analyst Forecast
The average price target for SNCY is $16.20, which is 57.13% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.20 |
| Price Target Difference | 57.13% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |
